Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Quantrill, S. J.
Right arrow Articles by Gokal, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quantrill, S. J.
Right arrow Articles by Gokal, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 1024-1027
© 2001 European Renal Association-European Dialysis and Transplant Association

Peritoneal tuberculosis in patients receiving continuous ambulatory peritoneal dialysis

Simon J. Quantrill1,, Mark A. Woodhead1, Christine E. Bell1, Alastair J. Hutchison2 and Ram Gokal2

1 Department of Respiratory Medicine, 2 Department of Renal Medicine, Manchester Royal Infirmary, Manchester, UK

Background. Patients with chronic renal failure have an increased risk of tuberculosis (TB). This occurs with much higher frequency within the first 12 months of initiating dialysis and is usually extrapulmonary in nature. Patients most at risk are those from susceptible ethnic groups, especially the Indian subcontinent. Peritoneal TB, otherwise relatively uncommon, has emerged as an important form of TB in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).

Methods. All cases of peritoneal TB occurring at our institution in patients undergoing CAPD over a 13 year period were identified and analysed.

Results. Eight cases were identified, of which seven were non-Caucasian. These patients’ characteristics and outcomes are presented. All were undergoing CAPD and most developed TB within 12 months of initiating dialysis. All presented with fever, but symptoms and signs were indistinguishable from bacterial peritonitis. Six were culture-positive, mainly from peritoneal dialysis fluid, but only two cases proved smear-positive. All were treated with standard anti-tuberculous chemotherapy. Three went on to permanent haemodialysis as a result of peritonitis and three have died, one of these as a result of TB.

Conclusions. Peritoneal TB, whilst otherwise relatively uncommon, is an important manifestation of TB in CAPD patients and usually develops soon after commencing dialysis. The reasons for this are unknown and require further research.

Keywords: chronic renal failure; CAPD; ethnic groups; patient characteristics; peritoneal tuberculosis

Correspondence and offprint requests to: Dr Simon Quantrill, Department of Cystic Fibrosis, Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RadioGraphicsHome page
S. Stuart, T. C. Booth, C. J. C. Cash, A. Hameeduddin, J. A. Goode, C. Harvey, and A. Malhotra
Complications of Continuous Ambulatory Peritoneal Dialysis1
RadioGraphics, March 1, 2009; 29(2): 441 - 460.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
T. Akpolat
TUBERCULOUS PERITONITIS
Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S166 - S169.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
Y.-M. HUNG, H.-H. CHAN, and H.-M. CHUNG
TUBERCULOUS PERITONITIS IN DIFFERENT DIALYSIS PATIENTS IN SOUTHERN TAIWAN
Am J Trop Med Hyg, May 1, 2004; 70(5): 532 - 535.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S.J. Quantrill, M.A. Woodhead, C.E. Bell, C.C. Hardy, A.J. Hutchison, and R. Gokal
Side-effects of antituberculosis drug treatment in patients with chronic renal failure
Eur. Respir. J., August 1, 2002; 20(2): 440 - 443.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.